hyoscyamine has been researched along with mefenamic acid in 1 studies
| Studies (hyoscyamine) | Trials (hyoscyamine) | Recent Studies (post-2010) (hyoscyamine) | Studies (mefenamic acid) | Trials (mefenamic acid) | Recent Studies (post-2010) (mefenamic acid) |
|---|---|---|---|---|---|
| 99 | 1 | 55 | 1,180 | 158 | 267 |
| Protein | Taxonomy | hyoscyamine (IC50) | mefenamic acid (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 1.6 | |
| Myeloperoxidase | Homo sapiens (human) | 1.595 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.116 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 1.751 | |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 0.56 | |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 6.97 | |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 3.91 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
1 other study(ies) available for hyoscyamine and mefenamic acid
| Article | Year |
|---|---|
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |